Progesterone Withdrawal as the Primary Driver of Menstrual Cramping

Hormonal Mechanism

• Progesterone withdrawal during the late luteal phase, rather than estrogen decline, is the principal hormonal trigger for the onset of menstrual cramping and associated premenstrual symptoms【1】.

Clinical Evidence

• In women with premenstrual symptoms, cyclic attacks typically occur during the luteal phase when progesterone levels are highest and resolve with the onset of menses as progesterone drops【2】.
• GnRH‑analog therapy that suppresses ovulation and eliminates luteal‑phase hormonal fluctuations (including progesterone withdrawal) completely abolishes premenstrual symptoms, providing strong experimental support for the role of progesterone withdrawal【1】.

Diagnostic Utility

• Measuring serum progesterone at the time symptoms begin is clinically useful for identifying symptoms that are driven by luteal‑phase hormonal changes【3】.

Temporal Symptom Pattern

• Symptoms generally start several days before menses (when progesterone is declining), improve within a few days after menses begins (after progesterone has dropped), and become minimal within one week after menses【1】.

Uterine Physiology

• Progesterone withdrawal enhances uterine contractility, contributing directly to cramping pain【2】.

Clinical Implications

• Cramping is triggered by the withdrawal or fluctuation of progesterone, not by elevated absolute progesterone levels; therefore, clinicians should focus on hormonal dynamics rather than single progesterone measurements【3】.
• Absolute progesterone concentrations do not correlate with mood or physical symptoms; individual sensitivity to hormonal fluctuations is the key determinant of symptom severity【3】.